A Novel Preservation Solution Containing Quercetin and Sucrose for Porcine Kidney Transplantation

Transplantation Direct
Mikako GochiNaoto Matsuno

Abstract

In organ transplantation, the University of Wisconsin (UW) solution has been the gold standard for organ preservation. Quercetin (Que) has numerous antioxidant and anti-inflammatory activities, and sucrose (Suc) may be effective for cold storage (CS). This study aimed to investigate the in vitro protective effect of Que and Suc on cold injury to the kidney and to determine whether Que + Suc could improve ischemia-reperfusion injury during CS and hypothermic oxygenated perfusion (HOPE) in autologous transplantation models. BHK-21 cells were stored at 4°C for 3 days in UW solution for CS/machine perfusion (CS/MP-UW) with Que (33.1 μM, 3.3 μM, 0.33 μM) and Suc (0.1 M). In a porcine model of renal autologous transplantation, left kidney grafts were preserved under 3 conditions: group 1, CS preservation for 24 hours; group 2, CS preservation for 22 hours and HOPE with CS/MP-UW solution for 2 hours; and group 3, identical preservation as group 2, with Que and Suc added to the solution. Animals were euthanized on day 7 after autologous transplantation. After 3 days of CS preservation, the CS/MP-UW solution with Que (33.1 μM, 3.3 μM) and Suc showed significant cell protection against cold injury. In the porcine model of renal autologou...Continue Reading

References

Jan 1, 1990·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·K YanagaT E Starzl
Jan 1, 1995·Annual Review of Medicine·J H Southard, F O Belzer
Aug 1, 1993·Free Radical Biology & Medicine·M L BarnardJ F Turrens
Feb 12, 2000·Transplantation·M M PolyakM Kinkhabwala
Dec 16, 2000·Transplantation·A K SalahudeenJ K Jenkins
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Francisco Pérez-VizcaínoJuan Tamargo
Nov 5, 2002·Cell Biochemistry and Function·Mine InalMehmet D Bilgin
Feb 6, 1959·Annals of the New York Academy of Sciences·A LEAF
Jun 18, 2004·Kidney International·Niaz AhmadJ Peter A Lodge
Jan 11, 2005·The American Journal of Clinical Nutrition·Claudine ManachChristian Rémésy
Oct 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Evangelia SpandouDimitrios Tsakiris
Apr 18, 2008·European Journal of Pharmacology·Agnes W BootsAalt Bast
Jun 24, 2008·Phytotherapy Research : PTR·Young Mi SeokKwon Moo Park
Aug 19, 2010·Oxidative Medicine and Cellular Longevity·Maqsood M ElahiBashir M Matata
May 14, 2011·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Edgardo E GuibertBarry J Fuller
Mar 1, 2010·Environmental Toxicology and Pharmacology·Chan-Min LiuJie-Qiong Ma
Aug 11, 2012·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Yuriy Y YushkovMichael J Goldstein
Sep 13, 2012·Experimental and Therapeutic Medicine·M Kenan KinaciMurat Tosun
Dec 20, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Dieter P HoyerZoltan Mathé
Sep 12, 2015·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Seiichiro NishidaHiroyasu Satoh
Oct 18, 2016·Annals of Surgery·Philipp KronPhilipp Dutkowski
Jun 8, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Avegail Flores, Sumeet K Asrani
Mar 2, 2018·Transplant International : Official Journal of the European Society for Organ Transplantation·Shaifali SandalRuth Sapir-Pichhadze
Aug 23, 2019·The Journal of Surgical Research·Hiroyuki KanazawaNaoto Matsuno
Jan 15, 2020·Annals of Transplantation : Quarterly of the Polish Transplantation Society·Daisuke IshiiHiroyuki Furukawa

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

EZR

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.